The correlation between TCRm-mediated ADCC signaling and antigen density suggests that the therapeutic formatting of TCRm Ab could depend on the antigen expression on tumor cells, as seen for the WT1 TCRm Ab11,33. The gene discussed is WT1; the disease is neoplasm.